Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2018 Filed Feb 9, 2018 21:01 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004901 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,314.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 37.8767 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:59 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 296 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004898 · form4.xml · derivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,988 Underlying: Common Stock · 296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18 F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18 F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:59 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 105 | $169.66 | $17,814.30 |
DisclosureSEC source: 0001127602-18-004898 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,980 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:59 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004898 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:57 UTC |
Williams R SandersDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004897 · form4.xml · derivative · entry 2 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:57 UTC |
Williams R SandersDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004897 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:56 UTC |
Schechter Adam HDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004896 · form4.xml · derivative · entry 3 Schechter Adam H · CIK 0001376841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:56 UTC |
Schechter Adam HDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004896 · form4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:54 UTC |
Parham Richelle PDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004895 · form4.xml · derivative · entry 2 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:54 UTC |
Parham Richelle PDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004895 · form4.xml · nonDerivative · entry 1 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:53 UTC |
NEUPERT PETER MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004894 · form4.xml · derivative · entry 2 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:53 UTC |
NEUPERT PETER MDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004894 · form4.xml · nonDerivative · entry 1 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:52 UTC |
MITTELSTAEDT ROBERT E JRDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004893 · form4.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:52 UTC |
MITTELSTAEDT ROBERT E JRDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004893 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:50 UTC |
Kong GarhengDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004892 · form4.xml · derivative · entry 2 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:50 UTC |
Kong GarhengDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004892 · form4.xml · nonDerivative · entry 1 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:49 UTC |
Gilliland Dwight GaryDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004891 · form4.xml · derivative · entry 2 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:49 UTC |
Gilliland Dwight GaryDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004891 · form4.xml · nonDerivative · entry 1 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:47 UTC |
BELINGARD JEAN-LUCDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004890 · form4.xml · derivative · entry 3 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:47 UTC |
BELINGARD JEAN-LUCDirector
|
Tax withholdingCommon Stock | 127 | $169.66 | $21,546.82 |
DisclosureSEC source: 0001127602-18-004890 · form4.xml · nonDerivative · entry 2 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,079 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:47 UTC |
BELINGARD JEAN-LUCDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004890 · form4.xml · nonDerivative · entry 1 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:44 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004889 · form4.xml · derivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:44 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004889 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 14:31 UTC |
Gilliland Dwight GaryDirector
|
SaleCommon Stock | 971 | $153.52 | $149,067.92 |
DisclosureSEC source: 0001127602-17-030671 · form4.xml · nonDerivative · entry 1 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,501 Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 15:18 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 970 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028201 · form4.xml · derivative · entry 1 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 Underlying: Common Stock · 970 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on 9/25/2020. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on 9/25/2020. Read SEC document |
| September 08, 2017 Filed Jan 23, 2018 14:06 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 1,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002231 · form5.xml · nonDerivative · entry 4 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 0 Read SEC document |
| September 08, 2017 Filed Jan 23, 2018 14:06 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 9,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002231 · form5.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 0 Read SEC document |
| September 08, 2017 Filed Jan 23, 2018 14:06 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 47,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002231 · form5.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 47,357 Read SEC document |
| September 08, 2017 Filed Jan 23, 2018 14:06 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 47,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002231 · form5.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,529.3298 F1 · balance_after: Amount reflects an annuity payment of 3,790 shares made by the reporting person's grantor retained annuity trust to the reporting person on November 16, 2017. F2 · balance_after: Amount includes 30.7478 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 19:35 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionNon-qualified Stock Options · Derivative | 44,687 | $0.00 Strike: $90.74 | $0.00 |
DisclosureSEC source: 0001127602-17-027134 · form4.xml · derivative · entry 7 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,687 shares Expires 2021-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on 02/09/2011 and is now fully exercisable. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 19:35 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 7,500 | $157.34 | $1,180,022.25 |
DisclosureSEC source: 0001127602-17-027134 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,065.582 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price of $157.3363 per share represents a weighted average of sales prices ranging from $157.225 to $157.430 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 19:35 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 37,187 | $156.77 | $5,829,761.37 |
DisclosureSEC source: 0001127602-17-027134 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,565.582 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price of $156.7688 per share represents a weighted average of sales prices ranging from $156.205 to $157.20 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 19:35 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 44,687 | $90.74 | $4,054,898.38 |
DisclosureSEC source: 0001127602-17-027134 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,752.582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 13:18 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionNon-qualified Stock Options · Derivative | 132,713 | $0.00 Strike: $90.74 | $0.00 |
DisclosureSEC source: 0001127602-17-027117 · form4.xml · derivative · entry 7 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,687 Underlying: Common Stock · 132,713 shares Expires 2021-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F7 · derivative.exercise_date: The option vested in three equal annual installments beginning on 02/09/2011 and is now fully exercisable. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 13:18 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 132,713 | $157.06 | $20,843,372.93 |
DisclosureSEC source: 0001127602-17-027117 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,065.582 F2 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price of $157.0560 per share represents a weighted average of sales prices ranging from $157.00 to $157.48 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · balance_after: Amount includes 156.9666 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan and annuity payments from each of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in notes 4 and 5 below. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 13:18 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 132,713 | $90.74 | $12,042,377.62 |
DisclosureSEC source: 0001127602-17-027117 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,778.582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F1 · balance_after: Amount includes 156.9666 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan and annuity payments from each of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in notes 4 and 5 below. Read SEC document |
| September 01, 2017 Filed Oct 23, 2017 20:10 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionRestricted Stock Unit · Derivative | 153 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-030206 · form4.xml · derivative · entry 3 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,037 Underlying: Common Stock · 153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| September 01, 2017 Filed Oct 23, 2017 20:10 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Tax withholdingCommon Stock | 51 | $157.61 | $8,038.11 |
DisclosureSEC source: 0001127602-17-030206 · form4.xml · nonDerivative · entry 2 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349.3653 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 193.3653 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| September 01, 2017 Filed Oct 23, 2017 20:10 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionCommon Stock | 153 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-030206 · form4.xml · nonDerivative · entry 1 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400.3653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 193.3653 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionNon-qualified Stock Options · Derivative | 9,200 | $0.00 Strike: $75.63 | $0.00 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · derivative · entry 7 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,200 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted persuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionNon-qualified Stock Options · Derivative | 14,100 | $0.00 Strike: $70.15 | $0.00 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · derivative · entry 6 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,100 shares Expires 2020-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted persuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionNon-qualified Stock Options · Derivative | 8,200 | $0.00 Strike: $60.04 | $0.00 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · derivative · entry 5 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,200 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted persuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
SaleCommon Stock | 31,500 | $155.22 | $4,889,470.95 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · nonDerivative · entry 4 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,694 F1 · price: The price of $155.2213 per share represents a weighted average of sales prices ranging from $155.01 to $155.62 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 9,200 | $75.63 | $695,796.00 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · nonDerivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 14,100 | $70.15 | $989,115.00 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:26 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 8,200 | $60.04 | $492,328.00 |
DisclosureSEC source: 0001127602-17-026620 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC |
Williams R SandersDirector
|
Exercise / conversionNon-qualified Stock Options · Derivative | 3,100 | $0.00 Strike: $77.19 | $0.00 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · derivative · entry 6 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,100 shares Expires 2020-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC |
Williams R SandersDirector
|
SaleCommon Stock | 11 | $156.92 | $1,726.12 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 5 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,973 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC |
Williams R SandersDirector
|
SaleCommon Stock | 8 | $156.91 | $1,255.28 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 4 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,984 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC |
Williams R SandersDirector
|
SaleCommon Stock | 2,881 | $156.90 | $452,020.55 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 3 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,992 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.